MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma

• Sameer A. Dhayat ,

  * E-mail: sameer.dhayat@ukmuenster.de

  Affiliation Department of General and Visceral Surgery, University Hospital Muenster, Muenster, Germany

  ⨯
• Wolf Arif Mardin,

  Affiliation Department of General and Visceral Surgery, University Hospital Muenster, Muenster, Germany

  ⨯
• Jochen Seggewiß,

  Affiliation Integrated Functional Genomics, Interdisciplinary Center for Clinical Research, Medical Faculty of the University of Muenster, Muenster, Germany

  ⨯
• Anda Jana Ströse,

  Affiliation Comprehensive Cancer Center Muenster, University Hospital Muenster, Muenster, Germany

  ⨯
• Christiane Matuszcak,

  Affiliation Department of General and Visceral Surgery, University Hospital Muenster, Muenster, Germany

  ⨯
• Richard Hummel,

  Affiliation Department of General and Visceral Surgery, University Hospital Muenster, Muenster, Germany

  ⨯
• Norbert Senninger,

  Affiliation Department of General and Visceral Surgery, University Hospital Muenster, Muenster, Germany

  ⨯
• Sören Torge Mees ,

  Contributed equally to this work with: Sören Torge Mees, Jörg Haier

  Affiliation Department of General and Visceral Surgery, University Hospital Muenster, Muenster, Germany

  ⨯
• Jörg Haier

  Contributed equally to this work with: Sören Torge Mees, Jörg Haier

  Affiliation Comprehensive Cancer Center Muenster, University Hospital Muenster, Muenster, Germany

  ⨯